Events & Media Partner Events

Topics: Carbon Capture, Hydrogen, Fuels for cars and aviation, Chemicals and Polymers as well as Mineralisation and Proteins The conference is aimed at providing international major players from the field of sustainable fuels, chemicals and polymers from CO2 with an opportunity to present and discuss their latest developments and strategies. The participants include interested experts from industry, associations, policy and civil society who wish to get a full picture of how this new and exciting scenario is unfolding. The conference provides an opportunity to meet the right partners for future alliances.



Info: nova-Institut, Dominik Vogt

Phone: +49-02233-4814-49, eMail: dominik.vogt@nova-institut.de

BIO-Europe Spring® is an essential event for anyone serious about partnering in the biotech industry. As the springtime counterpart of BIO-Europe, the conference encourages delegates to continue establishing and maintaining partnerships using EBD Group’s industry acclaimed approach.



Info: EBD Group, Tom Voigt

eMail: tvoigt@ebdgroup.com

The conference will address: – A General Counsel discussion on international developments around IP and competition – What to expect from the pharma incentives review and from the Supplementary Protection Certificate (SPC) Regulation – The SPC Manufacturing Waiver: what conclusions can be drawn? – Brexit: the IP landscape and business strategies for the sector – What’s new on Biosimilars: opportunities or challenges for biosimilar medicine developers? – The latest developments at the European Patent Office



Info: International Generic and Biosimilar Medicines Association (IGBA)

eMail: events@medicinesforeurope.com

During these two interactive days, leaders and experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and new trends. Discussion will focus on setting aims and implementing good practices to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to realise the access benefits. The various sessions will cover all relevant areas of healthcare policy, market access, scientific developments, regulatory and clinical experience.



Info: International Generic and Biosimilar Medicines Association (IGBA)

eMail: events@medicinesforeurope.com

Biosimilars - Development and regional differences, market access, pharmacovigilance, HCP and patient acceptance

Falsified Medicine Directive - First experiences

EU Health Technology Assessment - One assessment fits all?

Pediatric drug development - Challenges and possible solutions

Big data - Usefulness and usability

Medical Devices - apps, combination products, clinical trials and new regulations


Info: DGPharMed(Primecon

eMail: service@dgpharmed-jahrescongress.com